Status:
UNKNOWN
Immune Response Features in Allergic Airway Diseases
Lead Sponsor:
Lithuanian University of Health Sciences
Conditions:
Allergic Rhinitis
Allergic Asthma
Eligibility:
All Genders
18-65 years
Brief Summary
This study aims to investigate immune mechanisms and phenotypes and endotypes of allergic airway diseases - allergic rhinitis and allergic asthma. Pathogenesis of these diseases are not fully investig...
Eligibility Criteria
Inclusion
- Hypersensitivity to house dust mites
- Allergic rhinitis with or without mild to moderate asthma
Exclusion
- Acute or chronic infections
- Use of systemic immunosupresants (wait 1 month)
- Use of systemic or local antihistamines (wait 1 week)
- Use of intranasal steroids (wait 1 month)
- Oncological or active autoimmune diseases
Key Trial Info
Start Date :
May 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2024
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04352088
Start Date
May 1 2019
End Date
April 1 2024
Last Update
April 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital of Lithuanian University of Health Sciences Kauno klinikos
Kaunas, Lithuania